Use of a trans-signaling approach in chimeric antigen receptors
AssigneeThe Trustees of the University of Pennsylvania
InventorsDaniel J. Powell, Jr., Carl H. June
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions and methods for inducing a CAR mediated trans-signal in a T cell. The trans-signaling CAR T cells comprise a first CAR having a first signaling module and a second CAR having a distinct second signaling module. The present invention also provides cells comprising a plurality of types of CARs, wherein the plurality of types of CARs participate in trans-signaling to induce T cell activation.
Claims1
A trans-signaling composition comprising a nucleic acid molecule comprising a sequence encoding a first chimeric antigen receptor (CAR) and a second CAR, wherein the first CAR comprises a first antigen binding domain that binds mesothelin, a first CD8α hinge region, a CD8α transmembrane domain, and an intracellular CD3z signaling domain of a T cell receptor, and wherein the second CAR comprises a second antigen binding domain that binds folate receptor (FRa), a second CD8α hinge region, a CD28 transmembrane domain, and a CD28 intracellular domain, and wherein the first and second antigen binding domain is an antibody or fragment thereof, and wherein the nucleic acid sequence comprises SEQ ID NO:
- 4 and SEQ ID NO:
- 6.
Dependencies are inferred from the claim text.